Skip to main content
    N

    Novo Nordisk A/S (NVO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $41.60
    -0.03 (-0.07%)

    Market Cap: $183.52B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Novo Nordisk A/S (NVO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Novo Nordisk A/S are Sanofi ADR (SNY), Novartis AG ADR (NVS) and AstraZeneca (AZN). By market cap, Novo Nordisk A/S ranks 8th of the 13 companies on this page; Johnson & Johnson (JNJ) is the largest at $687.89B. The median P/E of the 10 companies with a P/E is 20.7x.

    Peer Comparison

    NVO's ROIC of 34.1% is above the peer median of 12.8%, and its revenue growth of 5.6% is below the median of 6.8%. Its dividend yield is above the peer median of 2.35%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    Johnson & Johnson (JNJ)$687.89B26.6x6.9x16.2%12.8%5.9%1.90%
    Peer median$230.18B20.7x5.0x14.3%12.8%6.8%2.35%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Novo Nordisk A/S, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Novartis AG ADR (NVS)
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    AstraZeneca PLC (AZN)
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    GSK plc (GSK)
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Gilead Sciences Inc (GILD)
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    Amgen Inc (AMGN)
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Biogen Inc (BIIB)
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    Johnson & Johnson (JNJ)
    Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
    JNJ competitors

    Frequently Asked Questions About NVO

    Who are Novo Nordisk A/S' main competitors?

    The companies most similar to Novo Nordisk A/S include Sanofi ADR (SNY), Novartis AG ADR (NVS), AstraZeneca (AZN), GSK (GSK) and Bristol-Myers Squibb Company (BMY), listed from the closest match.

    Who is Novo Nordisk A/S' biggest competitor?

    Johnson & Johnson (JNJ) is the largest of the similar companies at $687.89B; Sanofi ADR (SNY) is the closest match by business profile, size, sector and industry.

    How does NVO stock compare with its competitors?

    NVO's P/S is 3.6x against a peer median of 5.0x; its net margin is 33.9% against a peer median of 14.3%.

    Which of Novo Nordisk A/S' competitors pays a higher dividend?

    Novo Nordisk A/S has a forward dividend yield of 4.32%. Pfizer (PFE) and Sanofi ADR (SNY) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Novo Nordisk A/S bigger than its competitors?

    No. Novo Nordisk A/S is 8th by market cap among the 13 companies on this page; the largest is Johnson & Johnson (JNJ) at $687.89B.